Millennium Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.6M Sell
457,114
-103,599
-18% -$425K ﹤0.01% 4060
2025
Q4
$1.89M Buy
560,713
+310,594
+124% +$807K ﹤0.01% 3997
2025
Q3
$328K Buy
250,119
+153,787
+160% +$159K ﹤0.01% 5302
2025
Q2
$69.1K Sell
96,332
-6,263,350
-98% -$4.92M ﹤0.01% 5569
2025
Q1
$9.35M Buy
6,359,682
+4,179,239
+192% +$9.95M 0.01% 2262
2024
Q4
$9.66M Buy
2,180,443
+1,254,571
+136% +$5.09M ﹤0.01% 2213
2024
Q3
$3.81M Sell
925,872
-402,888
-30% -$2.17M ﹤0.01% 3087
2024
Q2
$8.66M Buy
1,328,760
+867,316
+188% +$6.13M ﹤0.01% 2216
2024
Q1
$4.02M Sell
461,444
-510,691
-53% -$6.2M ﹤0.01% 3099
2023
Q4
$11.1M Buy
972,135
+794,782
+448% +$7.86M ﹤0.01% 2079
2023
Q3
$1.71M Sell
177,353
-77,716
-30% -$762K ﹤0.01% 3707
2023
Q2
$2.71M Sell
255,069
-1,127,479
-82% -$12.1M ﹤0.01% 3212
2023
Q1
$14.5M Sell
1,382,548
-2,607,394
-65% -$29.2M 0.01% 1607
2022
Q4
$49.4M Buy
3,989,942
+2,184,767
+121% +$24.8M 0.03% 759
2022
Q3
$18.7M Buy
1,805,175
+724,203
+67% +$8.21M 0.01% 1414
2022
Q2
$12.5M Buy
1,080,972
+28,858
+3% +$340K 0.01% 1769
2022
Q1
$13.2M Sell
1,052,114
-537,702
-34% -$6.16M 0.01% 1822
2021
Q4
$18.5M Buy
1,589,816
+44,334
+3% +$544K 0.01% 1507
2021
Q3
$20.2M Sell
1,545,482
-213,471
-12% -$2.76M 0.01% 1317
2021
Q2
$22.6M Buy
1,758,953
+775,496
+79% +$8.88M 0.01% 1098
2021
Q1
$11M Buy
983,457
+126,422
+15% +$1.34M 0.01% 1667
2020
Q4
$9.76M Buy
857,035
+778,749
+995% +$8.52M 0.01% 1762
2020
Q3
$704 Sell
78,286
-232,012
-75% -$2.31M ﹤0.01% 3375
2020
Q2
$3.2M Buy
310,298
+286,318
+1,194% +$2.93M ﹤0.01% 2156
2020
Q1
$242K Sell
23,980
-644,937
-96% -$7.58M ﹤0.01% 3291
2019
Q4
$8.9M Sell
668,917
-362,381
-35% -$4M 0.01% 1472
2019
Q3
$8.85M Buy
1,031,298
+649,831
+170% +$6.31M 0.01% 1360
2019
Q2
$4.17M Sell
381,467
-654,994
-63% -$7.34M 0.01% 1921
2019
Q1
$11.7M Sell
1,036,461
-602,997
-37% -$6.73M 0.02% 1130
2018
Q4
$14.2M Buy
1,639,458
+1,327,506
+426% +$15.2M 0.02% 909
2018
Q3
$4.82M Buy
311,952
+231,590
+288% +$3.66M 0.01% 1827
2018
Q2
$1.29M Buy
+80,362
New +$1.19M ﹤0.01% 2684
2018
Q1
Sell
-29,211
Closed -$367K 3858
2017
Q4
$367K Buy
+29,211
New +$382K ﹤0.01% 3245
2017
Q3
Sell
-39,712
Closed -$628K 3685
2017
Q2
$628K Sell
39,712
-125,659
-76% -$1.83M ﹤0.01% 2693
2017
Q1
$2.36M Sell
165,371
-149,970
-48% -$2.05M ﹤0.01% 1909
2016
Q4
$4.04M Sell
315,341
-93,390
-23% -$1.18M 0.01% 1473
2016
Q3
$5.44M Sell
408,731
-367,933
-47% -$4.3M 0.01% 1286
2016
Q2
$8.51M Buy
776,664
+633,419
+442% +$6.19M 0.02% 951
2016
Q1
$1.31M Sell
143,245
-206,014
-59% -$1.7M ﹤0.01% 2035
2015
Q4
$3.39M Sell
349,259
-1,117,266
-76% -$10.8M 0.01% 1623
2015
Q3
$12.8M Buy
1,466,525
+283,038
+24% +$2.64M 0.02% 799
2015
Q2
$12M Sell
1,183,487
-1,657,376
-58% -$19.3M 0.02% 872
2015
Q1
$38.1M Sell
2,840,863
-344,222
-11% -$4.52M 0.07% 360
2014
Q4
$40.9M Buy
3,185,085
+1,588,435
+99% +$18.2M 0.09% 306
2014
Q3
$17.3M Sell
1,596,650
-2,424,438
-60% -$27.8M 0.04% 570
2014
Q2
$51.6M Sell
4,021,088
-2,317,149
-37% -$25.2M 0.14% 135
2014
Q1
$65.4M Buy
6,338,237
+5,401,084
+576% +$60.7M 0.19% 97
2013
Q4
$9.11M Sell
937,153
-1,027,536
-52% -$9.22M 0.03% 775
2013
Q3
$19.5M Buy
1,964,689
+1,653,734
+532% +$16.2M 0.06% 360
2013
Q2
$2.59M Buy
+310,955
New +$3.77M 0.01% 1436

Other funds holding IRWD

Millennium Management's IRWD Position: Q1 2026 in Review

Millennium Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 18% in Q1 2026, selling an estimated $425K and leaving 457,114 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #4060.

Millennium Management first reported a position in IRWD in Q2 2013 and has held it in 50 quarters since. The position peaked at $65.4M in Q1 2014. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Millennium Management held 457,114 shares of Ironwood Pharmaceuticals worth $1.6M as of Q1 2026.
  • Millennium Management sold 103,599 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $425K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4060 holding.
  • Millennium Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Millennium Management's Ironwood Pharmaceuticals position peaked at $65.4M in Q1 2014.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.